Full-Time

Principal Product Manager

INT Digital Health

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Product Management
Product Strategy
Product
Required Skills
Agile
Product Management
Google Cloud Platform
Requirements
  • Bachelor’s degree in business, software engineering, industrial engineering, or a field tied to the product sector OR 5 years of equivalent professional experience in lieu of a degree.
  • A minimum of 9 years of relevant job experience in digital product management, with focus on digital health or pharma.
  • Experience working with cross-functional teams, including engineering, UX, Program management.
  • Experience working in an Agile SDLC with experience leading the entire product discovery effort, creating both functional and technical user stories.
  • Experience managing the development of regulated digital products (GCP, GXP, ISO 13485, IEC 62304).
  • Ability to quickly learn and take the lead on managing highly sophisticated technical products and systems including ML based algorithms.
Responsibilities
  • Partner closely with cross-functional teams to define and deliver on Moderna’s revolutionary Individualized Neoantiogen Therapy digital products and services for patients and providers, serving both internal and external (providers, CROs) customers and users.
  • Define and drive product strategy and roadmap.
  • Develop product solutions to execute on the market potential and benefits possible from applying Moderna’s technologies in the enterprise market.
  • Convert solution ideas into action through stories, mockups, and prototypes, bridging the gap between idea and product.
  • Launch new products and features, test their performance, and iterate quickly.
  • Connect the technical and business worlds.
  • Break down complex problems into steps that drive product development.
  • Deeply understand the digital health and pharma ecosystem markets, competition, and user requirements.
  • Develop solutions to problems by collaborating as needed across regions, product areas, and functions.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

15%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE